Today: 10 June 2026
Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal
30 December 2025
1 min read

Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

NEW YORK, December 30, 2025, 3:07 PM ET — Regular session

Shares of Almonty Industries Inc fell about 3.9% to $8.90 in afternoon trading on Tuesday after giving up an early rise, with the stock swinging between $8.90 and $9.39.

The pullback comes as investors focus on tungsten, a hard metal used in munitions, industrial tooling and electronics, at a moment when governments are pushing to secure strategic supply chains.

A CBS News report published on Monday said Chief Executive Lewis Black met U.S. officials, including at the White House, before touring Almonty’s Sangdong mine in South Korea and signing a deal tied to future tungsten supply for U.S. security needs; Black declined to discuss terms. Black told CBS the mine should be operational in the first quarter of 2026 and produce an estimated 1.2 million tons of tungsten ore a year. “It’s vital. It’s further than critical, it’s vital,” Black said. CBS News

Almonty said on Dec. 16 it delivered the first truckload of ore to Sangdong’s run-of-mine pad, a staging area where material is stockpiled before processing, calling it a step from development into active mining ahead of commercial production.

Earlier this month, Almonty closed an upsized $129.375 million underwritten share offering in the United States, led by BofA Securities, selling 20.7 million shares at $6.25 each. An underwritten offering is a stock sale where banks agree to buy shares and resell them to investors.

The company later withdrew its base shelf prospectus and a related U.S. registration statement, saying it did not intend further offerings under that framework after completing the equity raise.

A base shelf prospectus is a regulatory filing that can let a company sell shares or other securities over a set period without preparing a fresh prospectus for each transaction.

ALM closed at $9.26 on Monday and is up about 7% from its Dec. 18 close of $8.35, according to Stock Analysis data.

Investors are now watching for updates on commissioning and ramp-up at Sangdong, and for any disclosures that clarify the scale and duration of U.S.-linked supply commitments.

The next decisive catalyst is execution: moving from first ore and test runs to steady output often exposes bottlenecks, cost pressure and timeline risk that can drive outsized moves in smaller mining stocks.

Stock Market Today

  • MindWalk Launches ReefIQ for Enhanced AI-Driven Drug Discovery
    June 10, 2026, 9:49 AM EDT. MindWalk Holdings Corp. (NASDAQ: HYFT) introduced ReefIQ™, a biological context layer designed to unify fragmented drug discovery data for AI analysis. The technology integrates diverse biological information such as sequences, structures, and assay results into a governed, queryable network. This enables MindWalk's LensAI tool and client-selected models to perform more accurate hypothesis generation and target discovery. By preserving data provenance and program history, ReefIQ aims to enhance trust and efficiency in regulated drug development environments. CEO Dr. Jennifer Bath emphasized that ReefIQ closes the data gaps in biological context, crucial for reliable AI-driven insights in life sciences.

Latest articles

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

10 June 2026
Rigetti Computing plunged 9.55% to $19.69 Tuesday and dipped further premarket after director Ray O. Johnson filed to sell 122,188 shares worth $2.6 million, testing investor confidence following a recent rally on news of a potential $100 million U.S. Commerce Department quantum-computing award, with traders watching for binding funding terms amid ongoing volatility.
PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake
Next Story

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake

Go toTop